Abbott Laboratories

Open: 91.1 Close: 92.18 Change: 1.08

You're running out of time to find out about Abbott Laboratories using an AI.

The game is changing. There is a new strategy to evaluate Abbott Laboratories fundamental value, possible risks and most salient advantages. Investors have traditionally relied in reading large amounts of text to evaluate the fundamental value of a stock or company. However, the development of Artificial Intelligence (AI) tools is modifying the way investments are evaluated in markets. Today, machine learning, natural language processing and bigdata allow making this process automatic, reducing large amounts of text to the elements that have a higher activation in a neural network. We programmed an artificial intelligence that reads the whole internet and the uses natural language processing and vectorizers to summarize the information. Usually, the AI reads several hundred pages and summarize it to a short document. This document presents our results. We found that the most common words in the internet about Abbott Laboratories are: Abbott, Laboratories, ABT, product, price, medical, company, …

Concept Map

Semantic Network

Stock Summary

Abbott Laboratories discovers, develops, manufactures, and sells health care products. The company operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Diagnostic segment offers laboratory systems in the.

Today's Summary

Abbott Laboratories shares rose 1.44%, to $92.18 Monday, on what proved to be an all-around positive trading session for the stock market. ABT stock has gained 26% since 2018.

Today's News

Shares of Abbott Laboratories ABT, +1.44% rose 1.44%, to $92.18 Monday, on what proved to be an all-around positive trading session for the stock market. Abbott Laboratories closed $23.65 short of its 52-week high ($115.83) Abbott Laboratories (ABT) discovers, develops, manufactures and sells a diversified range of healthcare products including branded generic pharmaceuticals, diagnostic systems and tests, and pediatric and adult nutritional products. The selling price or list price of a medical device is driven by numerous factors, such as therapy area and complexity of procedure. Abbott Laboratories (ABT) has a 66.44% payout ratio, which may leave the company with limited retained earnings, which could potentially impact its ability to reinvest in the business. The current ABT share price is $9087, making it technically a Sell. ABT is showing an implied volatility percentile of 99%. Abbott Laboratories share price is 90.87 USD today. Abbott Laboratories shares are forecast to RISE/FALL based on technical indicators. ABT stock has gained 26% since 2018. Abbott Laboratories CEO Robert Ford took the stage at the HLTH conference in Las Vegas on Tuesday to discuss the companys expansion into a new market: consumer wearables. The health-care company offers a range of products but derives the bulk of its revenue from medical devices and diagnostic tools. Investing in Abbott Laboratories five years ago would have delivered you a 52% gain. Abbott Laboratories is an international medical technology company headquartered in Chicago, Illinois. In 2013, Abbott Laboratories split into two separate companies, with Abbott remaining focused on medical products. Abbott Laboratories (ABT) - DEFM14A - Proxy Statement - Merger or Acquistion (definitive) SEC Filings Fri, Mar. 17 Abbott Laboratories - DEFA14A. - Additional Proxy Soliciting Materials.

Stock Profile

"Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for the treatment of pancreatic exocrine insufficiency, irritable bowel syndrome or biliary spasm, intrahepatic cholestasis or depressive symptoms, gynecological disorder, hormone replacement therapy, dyslipidemia, hypertension, hypothyroidism, Ménière's disease and vestibular vertigo, pain, fever, inflammation, and migraine, as well as provides anti-infective clarithromycin, influenza vaccine, and products to regulate physiological rhythm of the colon. The Diagnostic Products segment offers laboratory systems in the areas of immunoassay, clinical chemistry, hematology, and transfusion; molecular diagnostics systems that automate the extraction, purification, and preparation of DNA and RNA from patient samples, as well as detect and measure infectious agents; point of care systems; cartridges for testing blood; rapid diagnostics lateral flow testing products; molecular point-of-care testing for HIV, SARS-CoV-2, influenza A and B, RSV, and strep A; cardiometabolic test systems; drug and alcohol test, and remote patient monitoring and consumer self-test systems; and informatics and automation solutions for use in laboratories. The Nutritional Products segment provides pediatric and adult nutritional products. The Medical Devices segment offers rhythm management, electrophysiology, heart failure, vascular, and structural heart devices for the treatment of cardiovascular diseases; and diabetes care products, as well as neuromodulation devices for the management of chronic pain and movement disorders. Abbott Laboratories was founded in 1888 and is based in North Chicago, Illinois."

Keywords

How much time have you spent trying to decide whether investing in Abbott Laboratories? Many investors start with the dream of being free. They expect to find on the stock market an option to have time to develop their own interests and hobbies. That is, a way to escape a 9 to 5 job. However, investment is complex and investors end up spending whole days (and nights) trying to figure out which the right stock to invest is. The dream of stock investing becomes the nightmare of facing infinity amounts of information. As a solution, we programmed an artificial intelligence that reads the whole internet and the uses natural language processing and vectorizers to summarize the information. Usually, the AI reads several hundred pages and summarize it to a short document. This document presents our results. We found that the most common words in the internet about Abbott Laboratories are: Abbott, Laboratories, ABT, product, price, medical, company, and the most common words in the summary are: abbott, laboratory, stock, abt, market, best, dividend, . One of the sentences in the summary was: Abbott Laboratories shares rose 1.44%, to $92.18 Monday, on what proved to be an all-around positive trading session for the stock market. Other searches related to this term that the AI found were: stockmarketlive, livestock, stockmarketforbeginners, thestockmarket, stockmarkettoday, stockmarkettrading, stockmarketstocks, todaystockmarket, thestockmarket, marketnews, stockmarketnews, whatisstockmarket, usstockmarket, stockmarketopen. #abbott #laboratory #stock #abt #market #best #dividend.